Live Breaking News & Updates on Indomethacins impact on oxygen need

Stay informed with the latest breaking news from Indomethacins impact on oxygen need on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Indomethacins impact on oxygen need and stay connected to the pulse of your community

Researchers to study Indomethacin's impact on oxygen need in Covid patients

Researchers to study Indomethacin’s impact on oxygen need in Covid patients
April 28, 2021
×
After seeing encouraging results in a pilot study done last year, Indian researchers are now planning to conduct a randomised control trial (RCT) to understand the efficacy and safety of indomethacin in providing faster symptomatic relief and reduction in oxygen requirement in Covid-19 patients.
Indomethacin is a nonsteroidal, anti-inflammatory drug (NSAID) commonly used to reduce fever, pain, stiffness, and swelling caused by rheumatoid arthritis.
In December 2020, Medrxiv published a preprint of a study conducted by a group of doctors, who advanced the case use of Indomethacin for faster symptomatic relief and preventing progression of pneumonia in Covid-19 patients.

Wardha , Maharashtra , India , Chennai , Tamil-nadu , Nellore , Andhra-pradesh , R-krishna-kumar , Rajan-ravichandran , Datta-meghe-institute-of-medical-sciences , Department-of-engineering-design , Indian-council-for-medical-research